Neuberg Diagnostics to invest INR 150 crore to expand reach in North & East India

Regional Reference Lab in Delhi NCR for North India will be operational from January 2021. Dr Amrita Singh appointed to oversee the technical operations

0
37
New Delhi: Neuberg Diagnostics, India’s leading diagnostics lab chain plans to invest up to INR 150 crores for organic and inorganic business growth in the cities of Delhi and Kolkata during the year 2021.
Dr. Amrita Singh, an experienced industry expert, has been appointed as Chief of Lab Services for the region. She will be overseeing the company’s expansion and technical operations in North and East India. 
Currently, with more than 80 labs and 1000 touchpoints, Neuberg Diagnostics is present in India, UAE and South Africa. By onboarding the top laboratories like Bangalore based Anand Diagnostics Laboratory; Ahmedabad based Supratech Micropath; Pune based A.G Diagnostics; Chennai based Ehrlich Lab; Dubai based Minerva Lab; and South Africa based Global Lab – Neuberg has created a strong foothold in Gujarat, Tamil Nadu, Karnataka, Andhra Pradesh, Telangana, Maharashtra, and Kerala in India as well as in UAE & South Africa.
The company aims to add another 10 labs in the next quarter and 30 labs by end of next fiscal. It also plans to commence commercial operations in the USA in next quarter.
Dr. GSK Velu, Chairman and Managing Director, Neuberg Diagnostics said, “We started with a mission to make advanced diagnostics accessible and affordable to everyone. With a commitment to provide affordable diagnostics, we are now rolling out our quality routine and referral lab testing services in North & East India. Additionally, we are aiming to launch new generation techniques that are deployed for diagnosing complicated diseases where deeper analysis is required.
South and West have been our focus markets over the past three years. We are already leaders in markets like Karnataka, Gujarat, Tamil Nadu, Kerala and South Maharashtra, and are expanding our presence in other key markets like Andhra Pradesh & Telangana and Mumbai in Maharashtra by next quarter. Now we want to be a significant player in North and East. In both regions, we are looking for organic and inorganic growth catering to the testing needs.”
Mr. A Ganesan, Vice Chairman Neuberg Diagnostics said, “Currently, through hospital lab management and customer walk-in centres, we already have a presence in Delhi NCR and Chandigarh. Bringing on board Dr. Amrita Singh and a senior leadership team based in Delhi and Kolkata will provide the necessary management bandwidth and technical expertise to grow our operations in North and East India over the next two years. Our northern growth will be similar to South and West India, which has enabled us to become one of the top 4 diagnostics path lab players within 3 years of our operations, since Oct 2017.”
Neuberg Diagnostics actively performs 6000+ pathological tests. Currently, it is conducting Covid-19 tests at its 10 ICMR approved labs in the country.